Cargando…

Which antiarrhythmic drug to choose after electrical cardioversion: A study on non-valvular atrial fibrillation patients

The relative efficacy of antiarrhythmic drugs (AADs) after electrical cardioversion are not well established. This study aimed to investigate the efficacies of different AADs for maintaining sinus rhythm (SR) after electrical cardioversion for atrial fibrillation (AF). We selected patients from a re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gwag, Hye Bin, Chun, Kwang Jin, Hwang, Jin Kyung, Park, Seung-Jung, Kim, June Soo, Park, Kyoung-Min, On, Young Keun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5963785/ https://www.ncbi.nlm.nih.gov/pubmed/29787592 http://dx.doi.org/10.1371/journal.pone.0197352

Ejemplares similares

Serological Predictors for the Recurrence of Atrial Fibrillation After Electrical Cardioversion
por: Kim, Sook Kyoung, et al.
Publicado: (2010)

Retraction: Serological Predictors for the Recurrence of Atrial Fibrillation After Electrical Cardioversion
por: Kim, Sook Kyoung, et al.
Publicado: (2023)

Facilitated electrical cardioversion: does the selection of the antiarrhythmic drug matter?
por: Dan, Gheorghe-Andrei, et al.
Publicado: (2019)

Outcomes of cardiac resynchronization therapy in patients with atrial fibrillation accompanied by slow ventricular response
por: Hwang, Jin Kyung, et al.
Publicado: (2019)

Cardiovascular Events of Electrical Cardioversion Under Optimal Anticoagulation in Atrial Fibrillation: The Multicenter Analysis
por: Shin, Dong Geum, et al.
Publicado: (2015)

Electrical PR Interval Variation Predicts New Occurrence of Atrial Fibrillation in Patients With Frequent Premature Atrial Contractions
por: Chun, Kwang Jin, et al.
Publicado: (2016)

Planning and monitoring of patients for electrical cardioversion for atrial fibrillation
por: Deuling, J. H. H., et al.
Publicado: (2011)

The Outcome of Electrical Cardioversion in Hyperthyroid Induced Atrial Fibrillation
por: Shah, Hriday, et al.
Publicado: (2023)

Right atrial thrombus formation in a dog after successful electrical cardioversion for atrial fibrillation
por: Karn, Marta, et al.
Publicado: (2023)

Staged hybrid procedure versus radiofrequency catheter ablation in the treatment of atrial fibrillation
por: Hwang, Jin Kyung, et al.
Publicado: (2018)

Sternal fracture after elective electrical cardioversion of atrial fibrillation
por: Vollmann, Dirk, et al.
Publicado: (2010)

Utilization and Predictors of Electrical Cardioversion in Patients Hospitalized for Atrial Fibrillation
por: Rochlani, Yogita M., et al.
Publicado: (2016)

Periprocedural anticoagulation in atrial fibrillation: Update on electrical cardioversion and ablation
por: van Vugt, S. P. G., et al.
Publicado: (2018)

Early afterdepolarizations and electrical storm after cardioversion for atrial fibrillation
por: Lypourlis, Dimitrios, et al.
Publicado: (2022)

Computational Modeling for Antiarrhythmic Drugs for Atrial Fibrillation According to Genotype
por: Hwang, Inseok, et al.
Publicado: (2021)

Machine Learning Prediction for the Recurrence After Electrical Cardioversion of Patients With Persistent Atrial Fibrillation
por: Kwon, Soonil, et al.
Publicado: (2023)

Left atrial longitudinal strain by speckle tracking as independent predictor of recurrence after electrical cardioversion in persistent and long standing persistent non-valvular atrial fibrillation
por: Moreno-Ruiz, Luis Antonio, et al.
Publicado: (2019)

Lipoprotein(a) and inflammation in patients with atrial fibrillation after electrical cardioversion
por: Naji, Franjo, et al.
Publicado: (2011)

Atrial Fibrillation Cycle Length and Atrial Size in Horses with and without Recurrence of Atrial Fibrillation after Electrical Cardioversion
por: De Clercq, D., et al.
Publicado: (2014)

Emerging Antiarrhythmic Drugs for Atrial Fibrillation
por: Saljic, Arnela, et al.
Publicado: (2022)

Antiplatelet Therapy Combinations and Thrombogenicity in Patients with Non-Valvular Atrial Fibrillation
por: Park, Yongwhi, et al.
Publicado: (2017)

Corrigendum: Computational modeling for antiarrhythmic drugs for atrial fibrillation according to genotype
por: Hwang, Inseok, et al.
Publicado: (2022)

Electric Cardioversion vs. Pharmacological with or without Electric Cardioversion for Stable New-Onset Atrial Fibrillation: A Systematic Review and Meta-Analysis
por: Prasai, Paritosh, et al.
Publicado: (2023)

Pharmacological cardioversion for atrial fibrillation and flutter
por: Cordina, J, et al.
Publicado: (2006)

Atrial fibrillation cardioversion following acupuncture
por: Dilber, Dario, et al.
Publicado: (2015)

Rivaroxaban in atrial fibrillation cardioversion: an update
por: Lavalle, Carlo, et al.
Publicado: (2019)

How to Optimize Cardioversion of Atrial Fibrillation
por: Airaksinen, K. E. Juhani
Publicado: (2022)

A Cardioversion and Renal Dysfunction Cascade: Cardioversion for Atrial Fibrillation, Acute Kidney Injury, and Recurrence of Atrial Fibrillation
por: Asemota, Iriagbonse R, et al.
Publicado: (2020)

Chronic atrial fibrillation in intensive care unit treated with electrical cardioversion: is it appropriate?
por: Murtigni, M, et al.
Publicado: (2010)

Racial and Sex Disparities in Anticoagulation After Electrical Cardioversion for Atrial Fibrillation and Flutter
por: Mentias, Amgad, et al.
Publicado: (2021)

Hypoglossal Nerve Stimulator-Induced Neurapraxia Following Electrical Cardioversion for Atrial Fibrillation
por: Yacono, Christian S., et al.
Publicado: (2021)

Association of Electrical Cardioversion with Brain Perfusion and Cognitive Function in Patients with Atrial Fibrillation
por: Kedžo, Josip, et al.
Publicado: (2023)

Beat-to-beat finger photoplethysmography in atrial fibrillation patients undergoing electrical cardioversion
por: Saglietto, Andrea, et al.
Publicado: (2023)

QT prolongation-related ventricular arrhythmia associated with atrial fibrillation electrical cardioversion
por: Rav Acha, M, et al.
Publicado: (2023)

Influence of body mass index on recurrence of atrial fibrillation after electrical cardioversion
por: Ligero, Carmen, et al.
Publicado: (2023)

Cardioversion in patients with newly diagnosed non-valvular atrial fibrillation: observational study using prospectively collected registry data
por: Pope, Marita Knudsen, et al.
Publicado: (2021)

The significance of the left atrial volume index in prediction of atrial fibrillation recurrence after electrical cardioversion
por: Toufan, Mehrnoush, et al.
Publicado: (2017)

Atrial fibrillatory rate as predictor of recurrence of atrial fibrillation in horses treated medically or with electrical cardioversion
por: Buhl, Rikke, et al.
Publicado: (2022)

Efficacy and Safety of Outpatient Clinic-based Elective External Electrical Cardioversion in Patients with Atrial Fibrillation
por: Son, Nguyen Khac Le, et al.
Publicado: (2020)

The Association Between the Use of Antiarrhythmic Drugs in Non-Valvular Atrial Fibrillation and Patient Prognosis Using Data from the China Atrial Fibrillation (China-AF) Registry
por: Hou, Xiao-Xia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4a5o9qgijfrd2ler87aiado2gf